Description

6-Amino-9-methyl-7-[(2E)-5-[(1R)-1,2,3,4,4a,7,8,8aα-octahydro-5-[[(1H-pyrrol-2-yl)carbonyloxy]methyl]-1,2β,4aα-trimethylnaphthalen-1α-yl]-3-methyl-2-pentenyl]-7H-purin-9-ium is a complex, high-purity nucleoside analog derivative of significant interest in advanced pharmaceutical research and development. Its intricate molecular architecture, featuring a modified purine base linked to a steroidal terpene-like moiety, makes it a critical intermediate for synthesizing novel therapeutic agents. This compound is primarily sought by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in developing targeted therapies.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel antiviral and anticancer drug candidates.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies related to nucleoside metabolism and signaling pathways.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.
• Reference Standard: Employed as an analytical standard in quality control and method development for related pharmaceutical products.
• Precursor for Prodrugs: Utilized in the development of prodrug formulations to enhance bioavailability and targeting.

Basic Information

Product Name	6-Amino-9-methyl-7-[(2E)-5-[(1R)-1,2,3,4,4a,7,8,8aα-octahydro-5-[[(1H-pyrrol-2-yl)carbonyloxy]methyl]-1,2β,4aα-trimethylnaphthalen-1α-yl]-3-methyl-2-pentenyl]-7H-purin-9-ium
CAS No.	88874-28-6
Molecular Formula	C₃₀H₄₄N₆O₂
Molecular Weight	508.71 g/mol
Synonyms	9-Methyl-6-amino-7-(3-methyl-2-pentenyl)-7H-purin-9-ium derivative; Modified Adenosine Analog; Steroid-Conjugated Purine; (1R,2S,4aS,8aS)-5-[(E)-5-(6-Amino-9-methyl-9H-purin-7-yl)-3-methylpent-2-en-1-yl]-1,2,4a-trimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl methyl 1H-pyrrole-2-carboxylate; 7-[(2E)-5-[(1R,4aS,8aS)-5-[(1H-Pyrrol-2-ylcarbonyloxy)methyl]-1,2,4a-trimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]-3-methyl-2-pentenyl]-6-amino-9-methyl-7H-purin-9-ium
EINECS	Contact for details

Quality Control

Our 6-Amino-9-methyl-7-[(2E)-5-[(1R)-1,2,3,4,4a,7,8,8aα-octahydro-5-[[(1H-pyrrol-2-yl)carbonyloxy]methyl]-1,2β,4aα-trimethylnaphthalen-1α-yl]-3-methyl-2-pentenyl]-7H-purin-9-ium is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS, to ensure it meets the exacting standards required for pharmaceutical research. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting batch-specific results.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or COA. This material is hygroscopic (moisture-sensitive) and should be handled under an inert atmosphere when appropriate to ensure long-term stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.